Drug intelligence / Profile preview

l-hydroxyproline

Development stage
Unknown
Modality
Small Molecules
Administration
Topical
01

Overview

L-hydroxyproline (trans-4-hydroxy-L-proline) is a non-essential amino acid and a primary constituent of collagen, where it plays a vital role in stabilizing the collagen triple helix through hydrogen bonding. It is produced biologically via the post-translational hydroxylation of proline residues by the enzyme prolyl hydroxylase. While it is extensively used as a pharmaceutical intermediate in the synthesis of various drugs, most notably the HIV protease inhibitor atazanavir, it also has direct clinical applications. It is utilized as a diagnostic biomarker for conditions involving high collagen turnover, such as bone resorption and liver fibrosis. Therapeutically, l-hydroxyproline is incorporated into topical formulations to promote the repair of superficial wounds by supporting extracellular matrix synthesis. It is commercially produced through fermentation processes, with major suppliers including Evonik.

Brand names
Cicactive
Other names
trans-4-hydroxy-L-prolinetrans4-hydroxy-L-prolinetrans 4-hydroxy-L-proline4-hydroxy-L-proline(4R)-4-hydroxy-L-prolineL-4-hydroxyprolineL4-hydroxyprolineL 4-hydroxyproline
02

Targets

CTH (Cystathionine gamma-lyase)

Beyond the preview

Go deeper on l-hydroxyproline.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on l-hydroxyproline.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call